Point-of-Care Molecular Diagnostics Market to Achieve Significant Growth in the Near Future | Abaxis, Abbott, Binx Health, bioMérieux SA, Danaher, F. Hoffmann-La Roche Ltd, GenePOC, Mesa Biotech, Quidel Corporation

An off-the-shelf report on Point-of-Care Molecular Diagnostics Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.

Point-of-care test is conducted on patients at or near a site where a patient encounters the healthcare system. The test has a rapid turnaround time and offers necessary information to conduct further treatment of a patient. The molecular methods of diagnosis are being preferred due to speed, low cost, and ease of use for POC applications.

Request Sample Copy is Available at: http://bit.ly/2tr7hyd

The ability to diagnose infectious diseases at the site with limited infrastructure is expected to fuel the growth of the point-of-care molecular diagnostics market during the forecast period. Moreover, growing R&D activities for development in molecular diagnostics tests is anticipated to offer significant growth opportunities in the market.

Point-of-Care Molecular Diagnostics Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

Profiles of Key Point-of-Care Molecular Diagnostics Manufacturing Companies:
1. Abaxis
2. Abbott
3. Binx Health, Inc.
4. bioMérieux SA
5. Danaher
6. F. Hoffmann-La Roche Ltd
7. GenePOC Inc.
8. Mesa Biotech
9. Quidel Corporation
10. Siemens Healthineers

The "Global Point-Of-Care Molecular Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product & services, technology, application, end user, and geography. The global market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading point-of-care molecular diagnostics market players and offers key trends and opportunities in the market.

Don’t miss out on business opportunities in Point-of-Care Molecular Diagnostics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

Point-of-Care Molecular Diagnostics Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.

North America is expected to contribute to the largest share in the point-of-care molecular diagnostics market in the coming years, owing to rising prevalence of infectious diseases and availability of government initiatives in United States and Canada. Also, Asia Pacific is anticipated to witness steady growth during the forecast period, due to lower availability of large clinical testing spaces as well as the need for clinical tests in nations such as China and India.

The report segments the Global Point-of-Care Molecular Diagnostics Market as follows:

1.1.1 Global Point-of-Care Molecular Diagnostics Market – By Product & Services
• software & services
• assays & kits
• instruments/analyzers

1.1.2 Global Point-of-Care Molecular Diagnostics Market – By Technology
• real time PCR
• isothermal nucleic acid amplification technology (INAAT)

1.1.3 Global Point-of-Care Molecular Diagnostics Market – By Application
• oncology
• exually transmitted diseases
• hospital-acquired infections

1.1.4 Global Point-of-Care Molecular Diagnostics Market – By End User
• physician offices
• hospital emergency departments & intensive care units
• research institutes

1.1.5 Global Point-of-Care Molecular Diagnostics Market – By Geography

• North America
o U.S.
o Canada
o Mexico

• Europe
o France
o Germany
o Italy
o Spain
o UK
o Rest of Europe

• Asia Pacific (APAC)
o Australia
o China
o India
o Japan
o Rest of Asia-Pacific

• Middle East & Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Rest of MEA

• South America (SAM)
o Brazil
o Rest of SAM

Inquiry for Discount: http://bit.ly/2tiKm8b

Table Of Content:

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Point-of-Care Molecular Diagnostics Market- By Product & Services
1.3.2. Point-of-Care Molecular Diagnostics Market- By Technology
1.3.3. Point-of-Care Molecular Diagnostics Market- By Application
1.3.4. Point-of-Care Molecular Diagnostics Market- By End User
1.3.5. Point-of-Care Molecular Diagnostics Market- By Region
1.3.5.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.